These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24496929)

  • 1. α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma.
    Ito M; Hagiyama M; Mimae T; Inoue T; Kato T; Yoneshige A; Nakanishi J; Kondo T; Okada M; Ito A
    Breast Cancer Res Treat; 2014 Feb; 144(1):59-69. PubMed ID: 24496929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer cell motility is promoted by 14-3-3γ.
    Hiraoka E; Mimae T; Ito M; Kadoya T; Miyata Y; Ito A; Okada M
    Breast Cancer; 2019 Sep; 26(5):581-593. PubMed ID: 30830684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New challenges in pseudopodial proteomics by a laser-assisted cell etching technique.
    Mimae T; Ito A
    Biochim Biophys Acta; 2015 Jun; 1854(6):538-46. PubMed ID: 25461796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
    Park CK; Jung WH; Koo JS
    Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.
    Bergeron A; MacGrogan G; Bertaut A; Ladoire S; Arveux P; Desmoulins I; Bonnefoi H; Loustalot C; Auriol S; Beltjens F; Degrolard-Courcet E; Charon-Barra C; Richard C; Boidot R; Arnould L
    Mod Pathol; 2021 Jul; 34(7):1282-1296. PubMed ID: 33753865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Infiltration in Invasive Lobular Breast Cancer.
    Desmedt C; Salgado R; Fornili M; Pruneri G; Van den Eynden G; Zoppoli G; Rothé F; Buisseret L; Garaud S; Willard-Gallo K; Brown D; Bareche Y; Rouas G; Galant C; Bertucci F; Loi S; Viale G; Di Leo A; Green AR; Ellis IO; Rakha EA; Larsimont D; Biganzoli E; Sotiriou C
    J Natl Cancer Inst; 2018 Jul; 110(7):768-776. PubMed ID: 29471435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
    Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of DNA methylation-related proteins in invasive lobular carcinoma of breast: comparison to invasive ductal carcinoma.
    Cha YJ; Kim HM; Koo JS
    Histol Histopathol; 2017 Nov; 32(11):1175-1185. PubMed ID: 28111737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
    Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.
    Miše I; Vučić M
    Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
    Han A; Xiong M; Li Z; Liang Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
    Soslow RA; Carlson DL; Horenstein MG; Osborne MP
    Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status.
    Ameli F; Rose IM; Masir N
    Asian Pac J Cancer Prev; 2015; 16(6):2385-90. PubMed ID: 25824769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures.
    Tasdemir N; Bossart EA; Li Z; Zhu L; Sikora MJ; Levine KM; Jacobsen BM; Tseng GC; Davidson NE; Oesterreich S
    Cancer Res; 2018 Nov; 78(21):6209-6222. PubMed ID: 30228172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is invasive lobular carcinoma different from invasive ductal carcinoma?
    Mersin H; Yildirim E; Gülben K; Berberoğlu U
    Eur J Surg Oncol; 2003 May; 29(4):390-5. PubMed ID: 12711296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
    Frolik D; Caduff R; Varga Z
    Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.